The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer
Open Access
- 22 February 2020
- Vol. 12 (2), 513
- https://doi.org/10.3390/cancers12020513
Abstract
Prostate cancer (PCa) is the second most common cancer of men and is typically slow-growing and asymptomatic. The use of blood PSA as a screening method has greatly improved PCa diagnosis, but high levels of false positives has raised much interest in alternative biomarkers. We used next-generation sequencing (NGS) to elucidate the urinary transcriptome of whole urine collected from high-stage and low-stage PCa patients as well as from patients with the confounding diagnosis of benign hyperplasia (BPH). We identified and validated five differentially expressed protein-coding genes (FTH1 BRPF1, OSBP, PHC3, and UACA) in an independent validation cohort of small-volume (1 mL) centrifuged urine (n = 94) and non-centrifuged urine (n = 84) by droplet digital (dd)PCR. These biomarkers were able to discriminate between BPH and PCa patients and healthy controls using either centrifuged or non-centrifuged whole urine samples, suggesting that the urinary transcriptome is a valuable source of non-invasive biomarkers for PCa that warrants further investigation.Keywords
Funding Information
- Instituto de Salud Carlos III (PI12/00663, PIE13/00048, DTS14/00109, PI15/00275, PI18/01710)
This publication has 44 references indexed in Scilit:
- Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancerBMC Urology, 2012
- The mutational landscape of lethal castration-resistant prostate cancerNature, 2012
- Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasisParasitology International, 2012
- Changes in circulating microRNA levels associated with prostate cancerBritish Journal of Cancer, 2012
- Differential expression analysis for sequence count dataGenome Biology, 2010
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer AggressivenessCancer Epidemiology, Biomarkers & Prevention, 2010
- Oxysterol binding protein‐related protein‐5 is related to invasion and poor prognosis in pancreatic cancerCancer Science, 2008
- Androgen regulation of the androgen receptor coregulatorsBMC Cancer, 2008
- Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- Bortezomib as a Potential Treatment for Prostate CancerCancer Research, 2004